000			02149nam a22004695i 4500
001			978-1-4419-7188-3
003			DE-He213
005			20140220083722.0
007			cr nn 008mamaa
008			101209s2011 xxu| s |||| 0|eng d
020			_a9781441971883 _9978-1-4419-7188-3
024	7		_a10.1007/978-1-4419-7188-3 _2doi
050		4	_aRC261-271
072		7	_aMJCL _2bicssc
072		7	_aMED062000 _2bisacsh
082	0	4	_a614.5999 _223
100	1		_aTrump, Donald L. _eeditor.
245	1	0	_aVitamin D and Cancer _h[electronic resource] / _cedited by Donald L. Trump, Candace S. Johnson.
250			_a1.
264		1	_aNew York, NY : _bSpringer New York, _c2011.
300			_aXI, 342p. 15 illus., 8 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
520			_aThe following chapters provide excellent and comprehensive discussions of the potential role of vitamin D based therapies in breast, colorectal, prostate cancer and leukemia and myelodysplastic syndromes. These chapters also point out that the focus on these diseases is largely determined by the interests and expertise of the outstanding scientists who have chosen to pursue vitamin D based cancer therapeutics. To our knowledge, every tumor type ever evaluated has shown some biochemical and antiproliferative response to vitamin D. Similarly, vitamin D analogues, especially calcitriol, potentiate almost every cytotoxic agent with which combination therapies have been tested.
650		0	_aMedicine.
650		0	_aOncology.
650		0	_aToxicology.
650		0	_aNutrition.
650	1	4	_aBiomedicine.
650	2	4	_aCancer Research.
650	2	4	_aNutrition.
650	2	4	_aPharmacology/Toxicology.
700	1		_aJohnson, Candace S. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781441971876
856	4	0	_uhttp://dx.doi.org/10.1007/978-1-4419-7188-3
912			_aZDB-2-SBL
999			_c105706 _d105706